Regulatory Open Forum

 View Only
  • 1.  Pre-IND meeting request Guidance

    Posted 11-Dec-2023 10:45

    Dear All,

    For Pre-IND meeting request and brief package , how we can submit to FDA  via ESG portal or via nexgen ?

    Via ESG portal, pre-assigned number required?

    Regards,

    Sapna



    ------------------------------
    sapna rathi
    Regulatory specialist
    AHME
    India
    ------------------------------


  • 2.  RE: Pre-IND meeting request Guidance

    Posted 11-Dec-2023 13:11

    Hi Sapna,

    The ESG portal is the general route for all meeting request submissions. If your chemical compound subject matter is specific to CDER scope, then specifically you can use Nextgen. 

    You won't be submitting your briefing package until after your meeting request has been granted, at which time you will have been assigned an application number. 

    Hope this helps, 

    -Fenton



    ------------------------------
    Fenton Fong
    Vancouver BC
    Canada
    ------------------------------



  • 3.  RE: Pre-IND meeting request Guidance

    Posted 12-Dec-2023 04:17

    Dear Sir,

    Thank you for reply.

    From nexgen, can we submit through: FDA alternate submission option?

    Regards,

    Sapna.



    ------------------------------
    sapna rathi
    Regulatory specialist
    AHME
    India
    ------------------------------



  • 4.  RE: Pre-IND meeting request Guidance

    Posted 12-Dec-2023 12:50
    Edited by Fenton Fong 12-Dec-2023 12:52

    Hello Sapna,

    After my first reply, I'm not sure I understand what your question is below.

    In the interests of avoiding misunderstanding, my suggestion is for you to review: 

    https://cdernextgenportal.fda.gov/CDER_FAQ_Page#:~:text=FDA%20CDER%20NextGen%20Portal%20is,report%20information%20to%20the%20FDA.

    There is also a provided email address that you can contact for a direct answer to your query. 



    ------------------------------
    Fenton Fong
    Vancouver BC
    Canada
    ------------------------------